Loading…
CIK 0001534261 • 6 13F filings • May 15, 2025 – Aug 14, 2026
Import this data to Google Sheets with:
=jivedata("casdin-capital-llc","13f")Uses this filer's slug. Install the Jive Data add-on first; the second argument is "13f".
Past 5 quarters
| % of Portfolio | |||||
|---|---|---|---|---|---|
| 10X GENOMICS INC | CL A COM | $22.8M | 1.4% | 1,400,000 SH | New |
| ABSCI CORPORATION | COM | $3.4M | 0.2%Prev: 0.2% | 973,260 SH | Increased |
| ALNYLAM PHARMACEUTICALS INC | COM | $29.8M | 1.9%Prev: 2.1% | 75,000 SH | Increased+20,000 SH |
| ARS PHARMACEUTICALS INC | COM | $18.6M | 1.2%Prev: 1.3% | 1,600,000 SH | Increased |
| AVIDITY BIOSCIENCES INC | COM | $72.1M | 4.5%Prev: 6.5% | 1,000,000 SH | Decreased-780,000 SH |
| BEAM THERAPEUTICS INC | COM | $44.4M | 2.8%Prev: 3.2% | 1,600,000 SH | Increased |
| BIOLIFE SOLUTIONS INC | COM NEW | $144.0M | 8.9%Prev: 14.3% | 5,957,165 SH | Decreased-750,000 SH |
| BRIDGEBIO ONCOLOGY THERAPEUT | COM NEW | $3.5M | 0.2%Prev: 0.3% | 282,312 SH | Increased |
| CENTURY THERAPEUTICS INC | COM | $1.2M | 0.1%Prev: 0.1% | 1,228,190 SH | Increased |
| CONTINEUM THERAPEUTICS INC | CL A | $1.7M | 0.1%Prev: 0.1% | 148,333 SH | Decreased |
| DENALI THERAPEUTICS INC | COM | $30.4M | 1.9%Prev: 1.1% | 1,840,000 SH | Increased+950,000 SH |
| DEXCOM INC | COM | $11.6M | 0.7% | 175,000 SH | New |
| GENEDX HOLDINGS CORP | COM CL A | $391.1M | 24.3%Prev: 27.0% | 3,007,164 SH | Increased |
| GINKGO BIOWORKS HOLDINGS INC | CL A NEW | $303K | 0.0%Prev: 0.0% | 36,493 SH | Decreased |
| GUARDANT HEALTH INC | COM | $38.8M | 2.4%Prev: 0.5% | 380,000 SH | Increased+280,000 SH |
| HIMS & HERS HEALTH INC | COM CL A | $12.5M | 0.8%Prev: 1.1% | 385,000 SH | Decreased+155,000 SH |
| ILLUMINA INC | COM | $78.7M | 4.9%Prev: 4.2% | 600,000 SH | Increased+75,000 SH |
| INCYTE CORP | COM | $9.9M | 0.6%Prev: 0.7% | 100,000 SH | Increased |
| LEGEND BIOTECH CORP | SPONSORED ADS | $4.7M | 0.3% | 215,000 SH | New |
| MAZE THERAPEUTICS INC | COM | $31.4M | 2.0%Prev: 1.6% | 758,857 SH | Increased |
| MONTE ROSA THERAPEUTICS INC | COM | $1.3M | 0.1%Prev: 0.1% | 86,014 SH | Increased |
| NEUROGENE INC | COM | $26.7M | 1.7%Prev: 1.9% | 1,295,361 SH | Increased |
| PACIFIC BIOSCIENCES CALIF IN | COM | $7.9M | 0.5%Prev: 0.1% | 4,223,767 SH | Increased+3,500,000 SH |
| PRIME MEDICINE INC | COM | $11.0M | 0.7%Prev: 1.5% | 3,167,175 SH | Decreased |
| QUEST DIAGNOSTICS INC | COM | $8.7M | 0.5% | 50,000 SH | New |
| RECURSION PHARMACEUTICALS IN | CL A | $676K | 0.0%Prev: 0.1% | 165,323 SH | Decreased |
| RELAY THERAPEUTICS INC | COM | $110.0M | 6.8%Prev: 4.9% | 13,003,574 SH | Increased+1,662,193 SH |
| REVOLUTION MEDICINES INC | COM | $205.3M | 12.8%Prev: 10.3% | 2,577,333 SH | Increased-70,000 SH |
| SCHOLAR ROCK HLDG CORP | COM | $11.5M | 0.7% | 260,000 SH | New |
| SEPTERNA INC | COM | $15.4M | 1.0%Prev: 0.9% | 553,268 SH | Increased |
| STANDARD BIOTOOLS INC | COM | $113.6M | 7.1%Prev: 8.4% | 88,783,856 SH | Increased+11,225,000 SH |
| STRUCTURE THERAPEUTICS INC | SPONSORED ADS | $81.7M | 5.1%Prev: 3.6% | 1,175,000 SH | Increased-380,000 SH |
| TAYSHA GENE THERAPIES INC | COM SHS | $8.3M | 0.5% | 1,500,000 SH | New |
| TEMPUS AI INC | CL A | $17.4M | 1.1%Prev: 2.0% | 294,127 SH | Decreased |
| TENAYA THERAPEUTICS INC | COM | $258K | 0.0%Prev: 0.0% | 361,969 SH | Decreased |
| THE CIGNA GROUP | COM | $11.0M | 0.7% | 40,000 SH | New |
| UNITEDHEALTH GROUP INC | COM | $16.5M | 1.0%Prev: 0.7% | 50,000 SH | Increased+25,000 SH |
| VERACYTE INC | COM | $11.6M | 0.7%Prev: 0.8% | 276,308 SH | Increased |
| 13F-HR |
| 0000919574-26-005491 |
| $2.00B |
| View |
| Aug 14, 2025 | Q2 2025 | 13F-HR | 0000919574-25-004903 | $1.10B | View |
| May 15, 2026 | Q1 2026 | 13F-HR | 0000919574-26-003451 | $1.32B | View |
| May 15, 2025 | Q1 2025 | 13F-HR | 0000919574-25-003248 | $1.22B | View |